Novavax Announces Leadership Appointment and Updates

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

Related Keywords

Laura Keenan ,Erika Schultz ,Marco Cacciuttolo ,Alexandra Roy ,Alison Chartan ,Filip Dubovsky ,Denny Kim ,Raburn Mallory ,Johnson ,University Of Maryland ,University Of Chicago Pritzker School Medicine ,Nasdaq ,Dynport Vaccine Company ,Astrazeneca ,Pontifical Catholic University Of Valpara ,Nosocomial Vaccine Corporation ,Brown University ,Yale University School Medicine ,Novavax Inc ,Clinical Development ,Yale University ,Exchange Commission ,Head Of Clinical Development ,Master Of Public Health ,Analytical Development ,Senior Vice President ,Chief Safety Officer ,Global Vaccine ,Executive Vice President ,Chief Medical ,Chief Medical Officer ,Patient Safety ,Horizon Pharma ,Vaccine Business Unit ,Therapeutic Area Safety Head ,Chicago Pritzker School ,Public Health ,Johns Hopkins University Bloomberg School ,Vice President ,Global Clinical Lead ,Medical Director ,Dynport Vaccine ,Robert Wood Johnson Clinical Scholar ,Johns Hopkins University ,Academic Hospitalist ,Yale New Haven Hospital ,Biochemical Engineering ,Pontifical Catholic University ,Financial Condition ,Novavax Annual Report ,Quarterly Reports ,Novavax ,Nc ,